Altimmune, Inc. (NASDAQ:ALT) Q4 2024 Earnings Call Transcript February 27, 2025
Altimmune, Inc. beats earnings expectations. Reported EPS is $-0.33, expectations were $-0.34.
Operator: Good day, ladies and gentlemen, and welcome to Altimmune Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this call is being recorded. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to introduce your...
